<DOC>
	<DOC>NCT01936194</DOC>
	<brief_summary>This clinical trial will study the effects of PUFA supplementation during pregnancy and lactation period on fatty acid composition in human milk and plasma of the mothers and the clinical outcome of atopic dermatitis in infants at increased risk.</brief_summary>
	<brief_title>The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Woman is pregnant between 16 and 20 weeks Mother delivers after 36 weeks Mother is willing to breastfeed for four months Mother has potential to deliver a child with increased risk of atopic dermatitis Signed Informed Consent Mother is smoking Disease with influence on breast feeding Complicated pregnancy Allergic to seafood Allergic to soy Allergic to marine fish Mother has more than two salmon or tuna meals per week Mother is undergoing treatment with anticoagulants</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>